Matches in Nanopublications for { ?s ?p "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP109712.RAiY0iV_ynUEYyAMq97suSffBZ4qP50Lsx9Mat7eSiqvk130_assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109712.RAiY0iV_ynUEYyAMq97suSffBZ4qP50Lsx9Mat7eSiqvk130_provenance.
- NP109273.RAMXCHdcLQ0P2qGfL4McI4RadbGFq5RhIeMDTvM_GXsjg130_assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109273.RAMXCHdcLQ0P2qGfL4McI4RadbGFq5RhIeMDTvM_GXsjg130_provenance.
- NP172487.RAmv1W2UOaBCkWqctpg4qHYRc-GG1y4U_cIPb8dzjPydc130_assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172487.RAmv1W2UOaBCkWqctpg4qHYRc-GG1y4U_cIPb8dzjPydc130_provenance.
- assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP241619.RAXegCscgrBw-l7pPz_EDcu9XfeNKM_GSAoITyZi9DjWM130_assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241619.RAXegCscgrBw-l7pPz_EDcu9XfeNKM_GSAoITyZi9DjWM130_provenance.
- NP172925.RA2IhRoXpKwxRNF-5RPyVYyaY_VHyQNoeJjpN3g4Aw_Kw130_assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172925.RA2IhRoXpKwxRNF-5RPyVYyaY_VHyQNoeJjpN3g4Aw_Kw130_provenance.
- NP241620.RAy8BHlZhpNBC5SX4uVMwEkFfxMuBpzop0FPAxb0ush8A130_assertion description "[These results demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241620.RAy8BHlZhpNBC5SX4uVMwEkFfxMuBpzop0FPAxb0ush8A130_provenance.